Literature DB >> 15813867

Reporting of adverse events following immunization in Australia.

David Isaacs1, Glenda Lawrence, Ian Boyd, Kathlyn Ronaldson, John McEwen.   

Abstract

It is an important component of any immunization programme that vaccine safety is monitored by carrying out surveillance for adverse events following immunization (AEFI). Such surveillance can be active or passive. Active surveillance will detect more AEFI, but the vast majority will be minor events. Passive surveillance is probably more appropriate for routine AEFI surveillance, while active surveillance can be used to monitor a new vaccine or to test whether a specific severe event is significantly associated with immunization. Australia has a predominantly passive surveillance system. The system has recently been centralized, providing useful national data on vaccine safety.

Mesh:

Substances:

Year:  2005        PMID: 15813867     DOI: 10.1111/j.1440-1754.2005.00580.x

Source DB:  PubMed          Journal:  J Paediatr Child Health        ISSN: 1034-4810            Impact factor:   1.954


  4 in total

1.  Surveillance of adverse events following immunization of 13-valent pneumococcal conjugate vaccine among infants, in Zhejiang province, China.

Authors:  Yu Hu; Xuejiao Pan; Fuxing Chen; Ying Wang; Hui Liang; Linzhi Shen; Yaping Chen; Huakun Lv
Journal:  Hum Vaccin Immunother       Date:  2022-03-03       Impact factor: 3.452

2.  Active surveillance study of adverse events following immunisation of children in the Czech Republic.

Authors:  Jana Danova; Aneta Kocourkova; Alexander M Celko
Journal:  BMC Public Health       Date:  2017-02-06       Impact factor: 3.295

Review 3.  Participant-centred active surveillance of adverse events following immunisation: a narrative review.

Authors:  Patrick Cashman; Kristine Macartney; Gulam Khandaker; Catherine King; Michael Gold; David N Durrheim
Journal:  Int Health       Date:  2017-05-01       Impact factor: 2.473

4.  Healthcare providers' knowledge, experience and challenges of reporting adverse events following immunisation: a qualitative study.

Authors:  Adriana Parrella; Annette Braunack-Mayer; Michael Gold; Helen Marshall; Peter Baghurst
Journal:  BMC Health Serv Res       Date:  2013-08-15       Impact factor: 2.655

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.